title: Benzo[a]pyrene diol epoxide stimulates an inflammatory response in normal human lung fibroblasts through a p53 and JNK mediated pathway.
abstract: Cellular responses to carcinogens are typically studied in transformed cell lines, which do not reflect the physiological status of normal tissues. To address this question, we have characterized the transcriptional program and cellular responses of human lung WI-38 fibroblasts upon exposure to the ultimate carcinogen benzo[a]pyrene diol epoxide (BPDE). In contrast to observations in cell lines, we find that BPDE treatment induces a strong inflammatory response in these normal fibroblasts. Whole-genome microarrays show induction of numerous inflammatory factors, including genes that encode interleukins (ILs), growth factors and enzymes related to prostaglandin synthesis and signaling. Real-time reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA) revealed a time- and dose-dependent-induced expression and production of cyclooxygenase 2, prostglandin E2 and IL1B, IL6 and IL8. In parallel, cell cycle progression and DNA repair processes were repressed, but DNA damage signaling was increased via p53-Ser15 phosphorylation and induced expression levels of GADD45A, CDKN1A, BTG2 and SESN1. Network analysis suggested that activator protein 1 transcription factors may link the cell cycle response and DNA damage signaling with the inflammatory stress-response in these cells. We confirmed this hypothesis by showing that p53-dependent signaling through c-jun N-terminal kinase (JNK) led to increased cJun-Ser63 phosphorylation and that inhibition of JNK-mediated cJun activation using p53- or JNK-specific inhibitors significantly reduced IL gene expression and subsequent production of IL8. This is the first demonstration that a strong inflammatory response is triggered in normal fibroblasts by BPDE and that this occurs through coordinated regulation with other cellular processes.
authors.affiliation: Department of Biology, New York University, 1009 Silver Center, 100 Washington Square East, New York, NY 10003, USA.
authors.forename: Kristian
authors.initials: K
authors.lastname: Dreij
authors.forename: Kahn
authors.initials: K
authors.lastname: Rhrissorrakrai
authors.forename: Kristin C
authors.initials: KC
authors.lastname: Gunsalus
authors.forename: Nicholas E
authors.initials: NE
authors.lastname: Geacintov
authors.forename: David A
authors.initials: DA
authors.lastname: Scicchitano
mesh_terms: D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000139:chemically induced*; D008168:Lung / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D048670:MAP Kinase Kinase 4 / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D016159:Tumor Suppressor Protein p53; D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; D048670:MAP Kinase Kinase 4
references.citation: Am J Physiol Lung Cell Mol Physiol. 2004 Nov;287(5):L981-91
references.pmid: 15234907
references.citation: Mutat Res. 2004 May 18;549(1-2):43-64
references.pmid: 15120962
references.citation: IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
references.pmid: 15285078
references.citation: J Natl Cancer Inst. 2002 Feb 20;94(4):252-66
references.pmid: 11854387
references.citation: Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
references.pmid: 7568133
references.citation: Toxicol In Vitro. 2008 Mar;22(2):411-21
references.pmid: 18494146
references.citation: Toxicol Lett. 1982 Jan;10(1):109-18
references.pmid: 7080063
references.citation: Chem Res Toxicol. 2005 Apr;18(4):655-64
references.pmid: 15833025
references.citation: Toxicol Appl Pharmacol. 2008 Oct 15;232(2):309-16
references.pmid: 18671994
references.citation: Cell Cycle. 2007 Jul 15;6(14):1753-61
references.pmid: 17630511
references.citation: Science. 1999 Sep 10;285(5434):1733-7
references.pmid: 10481009
references.citation: Free Radic Biol Med. 2005 Nov 1;39(9):1177-83
references.pmid: 16214033
references.citation: J Environ Pathol Toxicol Oncol. 2007;26(4):281-94
references.pmid: 18197826
references.citation: J Leukoc Biol. 1999 Mar;65(3):291-8
references.pmid: 10080530
references.citation: Mutat Res. 2000 Nov 20;471(1-2):57-70
references.pmid: 11080661
references.citation: Carcinogenesis. 1999 May;20(5):859-65
references.pmid: 10334204
references.citation: Biostatistics. 2003 Apr;4(2):249-64
references.pmid: 12925520
references.citation: Genome Biol. 2003;4(1):R7
references.pmid: 12540299
references.citation: Cell. 2005 Feb 25;120(4):513-22
references.pmid: 15734683
references.citation: Mol Carcinog. 2007 Jan;46(1):32-41
references.pmid: 16921490
references.citation: Cancer Lett. 2007 Oct 28;256(2):137-65
references.pmid: 17629396
references.citation: BMC Bioinformatics. 2006 Jan 31;7:49
references.pmid: 16448562
references.citation: Science. 1998 Sep 11;281(5383):1674-7
references.pmid: 9733514
references.citation: Nature. 1974 Nov 22;252(5481):326-8
references.pmid: 4473724
references.citation: J Med Chem. 2006 Jun 15;49(12):3563-80
references.pmid: 16759099
references.citation: Cell Mol Life Sci. 2009 Mar;66(6):994-1009
references.pmid: 19153657
references.citation: Cancer Res. 2002 Sep 15;62(18):5288-94
references.pmid: 12234998
references.citation: Chem Res Toxicol. 2007 Dec;20(12):1797-810
references.pmid: 17944540
references.citation: Biol Pharm Bull. 2005 Jul;28(7):1244-8
references.pmid: 15997107
references.citation: Carcinogenesis. 2003 Feb;24(2):225-34
references.pmid: 12584171
references.citation: J Biol Chem. 2006 Jul 21;281(29):19906-15
references.pmid: 16679317
references.citation: Toxicol Lett. 2008 Mar 15;177(2):130-7
references.pmid: 18289803
references.citation: PLoS Biol. 2008 Dec 2;6(12):2853-68
references.pmid: 19053174
references.citation: Cancer Cell. 2004 Sep;6(3):203-8
references.pmid: 15380510
references.citation: Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129-57
references.pmid: 1751545
references.citation: Free Radic Biol Med. 2007 Jun 15;42(12):1858-65
references.pmid: 17512465
references.citation: Mol Cancer Ther. 2005 Sep;4(9):1369-77
references.pmid: 16170029
references.citation: Genes Dev. 1999 Jan 15;13(2):152-7
references.pmid: 9925639
references.citation: Environ Mol Mutagen. 2000;36(3):201-5
references.pmid: 11044901
references.citation: Clin Immunol. 2003 Apr;107(1):10-9
references.pmid: 12738245
references.citation: Oncogene. 2003 May 15;22(19):2993-3006
references.pmid: 12771951
references.citation: DNA Repair (Amst). 2008 Aug 2;7(8):1202-12
references.pmid: 18479980
references.citation: Genomics. 2009 Apr;93(4):332-42
references.pmid: 19150397
references.citation: Chem Biol Interact. 2002 Sep 20;141(1-2):77-95
references.pmid: 12213386
references.citation: Nature. 2002 Dec 19-26;420(6917):860-7
references.pmid: 12490959
references.citation: Proc Natl Acad Sci U S A. 2008 May 13;105(19):6846-51
references.pmid: 18474869
references.citation: Br Med J. 1977 Jun 25;1(6077):1645-8
references.pmid: 871704
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Biol Proced Online. 2006;8:1-10
references.pmid: 16446781
references.citation: Toxicol Lett. 2004 Jul 15;151(2):345-55
references.pmid: 15183459
references.citation: Cancer Cell. 2007 Jun;11(6):555-69
references.pmid: 17560336
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references.pmid: 11309499
references.citation: J Natl Cancer Inst. 1999 Jul 21;91(14):1194-210
references.pmid: 10413421
references.citation: Chem Res Toxicol. 2005 Apr;18(4):619-29
references.pmid: 15833022
references.citation: Carcinogenesis. 2008 Jan;29(1):202-10
references.pmid: 17942461
references.citation: Toxicol Lett. 2006 Aug 20;165(2):182-94
references.pmid: 16713138
references.citation: Bioinformatics. 2003 Jan 22;19(2):185-93
references.pmid: 12538238